Clinical Trial Update: Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 trial exploring Envafolimab with chemotherapy and recombinant human endostatin as first-line treatment for squamous non-small cell lung cancer is repo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Lung
• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Envafolimab (envafolimab)
• Recombinant human endostatin (recombinant human endostatin)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Squamous Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN